Lorazepam in phobic disorders: a pilot study.
D000284:Administration, Oral; D001007:Anxiety / Q000188:drug therapy; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005221:Fatigue / Q000139:chemically induced; D006801:Humans; D009048:Motor Skills / Q000187:drug effects; D010698:Phobic Disorders / Q000188:drug therapy*; D010865:Pilot Projects; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D013997:Time Factors; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D010919:Placebos; D014149:Tranquilizing Agents; D003975:Diazepam